Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Kodiak Sciences (NASDAQ:KOD) Rockets as Two Wet Macular Degeneration Drugs Win Phase 3 DAYBREAK Trials

● Kodiak Sciences (KOD) closed at $89.92 on Monday, up about 178% from $32.35, after positive Phase 3 DAYBREAK results.

Nitish Kishor | 29 September 2026

How Six-Month Dosing Hopes Turned Kodiak Sciences (NASDAQ:KOD) Into a Standout Biotech Winner

● Kodiak Sciences (KOD) closed at $89.92 on Monday, up about 178%, after Zenkuda data on longer dosing intervals.

Nitish Kishor | 29 September 2026

How Positive Phase 3 Data and a Planned Zenkuda Filing Powered Kodiak Sciences (NASDAQ:KOD)

● Kodiak Sciences (KOD) closed at $89.92 on Monday, about 178% above Friday's $32.35, after positive DAYBREAK data.

Nitish Kishor | 29 September 2026

How Contingent Value Rights Pushed Lifecore Biomedical (NASDAQ:LFCR) Above Its Cash Takeout Price

● Lifecore Biomedical (LFCR) closed at $6.52 on Monday, about 24 cents above the $6.28 cash price offered by Webster.

Nitish Kishor | 29 September 2026

Liquidia (NASDAQ:LQDA) Rallies as Strength Across Biotech Peers Lifts the Stock

● Liquidia (LQDA) closed at $73.67 on Monday, up about 7.7% from $68.43, while most of the market fell.

Nitish Kishor | 29 September 2026

MBX Biosciences (NASDAQ:MBX) Climbs on a Red Day for Wall Street

● MBX Biosciences (MBX) closed at $57.54 on Monday, up 7.3% from $53.63, while all three major indexes ended lower.

Nitish Kishor | 29 September 2026

Agenus (NASDAQ:AGEN) Jumps After Rodman & Renshaw Starts Coverage at Buy

● Agenus (AGEN) closed at $9.43 on Monday, up 10.4% from $8.54, after Rodman & Renshaw began coverage at Buy.

Nitish Kishor | 29 September 2026

How a Raymond James Rating Cut Put Acadia Healthcare (NASDAQ:ACHC) in Focus

● Acadia Healthcare (ACHC) closed at $27.91 on Monday, down 0.64% from $28.09, after Raymond James lowered its rating.

Nitish Kishor | 29 September 2026

Teleflex (NYSE:TFX) Stock: Medical Device Maker Draws Defensive Healthcare Interest

Shares of Teleflex (NYSE:TFX) ended Monday, September 28, 2026 higher by 4.35%, at $127.38. The company is a medical-device maker producing single-use and specialty devices used across hospitals and other care settings.

Nitish Kishor | 29 September 2026

PTC Therapeutics (NASDAQ:PTCT) Stock: Rare Disease Drugmaker Gains With Its Pipeline Front and Center

PTC Therapeutics (NASDAQ:PTCT) was among the gainers in US markets on Monday, September 28, 2026, closing the session up 5.23% at $65.95. The biopharmaceutical company develops and commercializes treatments for rare disorders, with commercial products and a pipeline.

Nitish Kishor | 29 September 2026
Support

Hi! How can we help you today?

Loading…